2022 ´ëÇѽŰæÁ¾¾çÇÐȸ Ãß°èÇмú´ëȸ : 2022-09-03±³À°ÀÏÀÚ : 2022-09-03
±³À°Àå¼Ò : »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ´ë°´ç
±³À°ÁÖÁ¦ :
(¿Â-¿ÀÇÁº´Çà) 2022 ´ëÇѽŰæÁ¾¾çÇÐȸ Ãß°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¾¾çÇÐȸ(ÀÎ)
´ã´çÀÚ : ÇÐȸ ºñ¼
¿¬¶ôó : 02-991-9043
À̸ÞÀÏ :
korea.sno@gmail.com ±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú, ½Å°æ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í Á¤È¸¿ø Àü¹®ÀÇ 50,000¿ø, ¼ö·Ãȸ¿ø, ºñȸ¿ø 30,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-03 ´ë°´ç 09:10~09:40 2021 WHO classification¿¡¼ ¼ºÀγú±³Á¾ÀÇ ¿µ»óÀû Ư¡ ¹ÚÁöÀº(¿ï»ê´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 09-03 ´ë°´ç 09:40~10:15 The 2021 WHO classification of CNS tumors: A brief overview ÀÌ°æÈ(Àü³²´ë º´¸®°ú)
±³À°½Ã°£ 09-03 ´ë°´ç 10:15~10:45 Methylome analysis for brain tumor diagnosis ¹Ú¼ºÇý(¼¿ï´ë º´¸®°ú)
ÈÞ½Ä 09-03 ´ë°´ç 10:45~11:00 ÈÞ½Ä ()
±³À°½Ã°£ 09-03 ´ë°´ç 11:00~11:20 Supratotal resection of glioblastoma ³ëÅÂÈÆ(¾ÆÁÖ´ë ½Å°æ¿Ü°ú)
±³À°½Ã°£ 09-03 ´ë°´ç 11:20~11:40 Tissue-agnostic anti-cancer therapy for glioma ¼°æÁø(¼¿ï´ë Ç÷¾×Á¾¾ç³»°ú)
±³À°½Ã°£ 09-03 ´ë°´ç 11:40~12:00 Radiotherapy for glioma with suspected CSF seeding À±È«ÀÎ(¿¬¼¼´ë ¹æ»ç¼±Á¾¾çÇаú)
½Ä»ç 09-03 ´ë°´ç 12:00~13:00 ½Ä»ç ()
±³À°½Ã°£ 09-03 ´ë°´ç 13:00~13:25 ´ëÇÑÁßȯÀÚÀÇÇÐȸ ±³À°¼ö·Ã ÇÁ·Î±×·¥ Á¤Àç½Â(°í·Á´ë ÈäºÎ¿Ü°ú)
±³À°½Ã°£ 09-03 ´ë°´ç 13:25~13:50 ´ëÇÑ¿Ü»óÇÐȸ ±³À°¼ö·Ã ÇÁ·Î±×·¥ Á¤ÇÊ¿µ(¿¬¼¼¿øÁÖÀÇ´ë ¿Ü°ú)
±³À°½Ã°£ 09-03 ´ë°´ç 13:50~14:20 Brain oncoimmunology ±ÇÈ£±Ù(¿¬¼¼´ë ¹Ì»ý¹°Çб³½Ç)
±³À°½Ã°£ 09-03 ´ë°´ç 14:20~14:50 Hypoxia and immune system ÀÌÈï±Ô(Ä«À̽ºÆ® ÀÇ°úÇдëÇпø)
ÈÞ½Ä 09-03 ´ë°´ç 14:50~15:10 ÈÞ½Ä ()
±³À°½Ã°£ 09-03 ´ë°´ç 15:10~15:40 Clinical practice guidelines for brain metastasis from solid tumors ¼º°æ¼ö(µ¿¾Æ´ë ½Å°æ¿Ü°ú)
±³À°½Ã°£ 09-03 ´ë°´ç 15:40~16:00 Guideline for anticonvulsant drug usage of brain tumor ¹®Àå¼·(¼¿ï´ë ½Å°æ°ú)
±³À°½Ã°£ 09-03 ´ë°´ç 16:00~16:30 2022 ASCO review ÀÌÃæ±Ù(¿¬¼¼´ë Á¾¾ç³»°ú)
±³À°½Ã°£ 09-03 ´ë°´ç 16:30~17:00 2022 WFNOS review ¾È½ºµ¥¹Ý(°¡Å縯´ë ½Å°æ¿Ü°ú)